FDA wins temporary halt on some morning-after pills
Key points
- Food and Drug Administration on Wednesday won a temporary halt to part of a court order directing it to make emergency contraception available to girls over the counter.
- Circuit Court of Appeals in New York said the FDA need not provide over-the-counter access to one-pill variants of emergency contraceptives while the agency appeals the April 5 order by U.S.
- However, the appeals court refused to halt the part of the order requiring access to two-pill variants, saying the FDA did not meet the standard necessary for a stay.
- Korman had ordered the FDA to lift age and point-of-access limits on emergency contraception, known as the "morning-after" pill or "Plan B," that helps prevent unwanted pregnancies.
The U.S. Food and Drug Administration on Wednesday won a temporary halt to part of a court order directing it to make emergency contraception available to girls over the counter.
The 2nd U.S. Circuit Court of Appeals in New York said the FDA need not provide over-the-counter access to one-pill variants of emergency contraceptives while the agency appeals the April 5 order by U.S. District Judge Edward Korman in Brooklyn, New York.
However, the appeals court refused to halt the part of the order requiring access to two-pill variants, saying the FDA did not meet the standard necessary for a stay.
Korman had ordered the FDA to lift age and point-of-access limits on emergency contraception, known as the "morning-after" pill or "Plan B," that helps prevent unwanted pregnancies.
The 2nd Circuit said it will hear the FDA's appeal on an expedited basis.
(Reporting by Jonathan Stempel; Editing by Sandra Maler)
###
(Reuters)
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Pregnancy & Fertility →
NewsConjoined twins seek life-saving surgery in Canada
Conjoined twins from Zimbabwe will undergo tests in Toronto to see whether they can survive a life-saving operation to separate them, Canadian doctors said on Tuesday. The 4-month-old twins, Tinashe and Tinotenda, were…
16 December 2004
NewsMorning-sickness med doesn't up malformation risk
Taking the anti-nausea drug ondansetron (Zofran) during pregnancy does not seem to increase the risk of major malformations in the baby, according to a new report. Ondansetron is approved for the treatment of nausea and…
2 October 2004
NewsMorning-after pill sparks controversy in Peru
A move by Peru's health minister to allow free distribution of the morning-after pill has sparked protests in the Roman Catholic country where abortion is banned and unmarried woman have only been allowed contraception…
